Carolyn R. Casella

The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4

Verónica Mata‐Haro, Caglar Cekic, Michael Martin et al. · Science · 2007 · 881 citations

Trif-biased Agonist, Innate Immune System, Immunology +22

Selective Activation of the p38 MAPK Pathway by Synthetic Monophosphoryl Lipid A

Caglar Cekic, Carolyn R. Casella, Chelsea A. Eaves et al. · Journal of Biological Chemistry · 2009 · 95 citations · Full text

Immunology, Immunologic Mechanism, Innate Immunity +19

MPL Adjuvant Contains Competitive Antagonists of Human TLR4

Yiqi Wang, Hélène G. Bazin, Jay T. Evans et al. · Frontiers in Immunology · 2020 · 87 citations · Full text

Vpu Increases Susceptibility of Human Immunodeficiency Virus Type 1-Infected Cells to Fas Killing

Carolyn R. Casella, Eric Rapaport, Terri H. Finkel · Journal of Virology · 1999 · 74 citations · Full text

Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF

Joseph P. Kolb, Carolyn R. Casella, Shuvasree SenGupta et al. · Science Signaling · 2014 · 42 citations · Full text